Literature DB >> 14685084

Primary hyperparathyroidism.

Göran Akerström1, Per Hellman.   

Abstract

PURPOSE OF REVIEW: This contribution presents research progress concerning primary hyperparathyroidism (pHPT), and the background for recent notable changes in treatment policy. RECENT
FINDINGS: Research has clarified that most patients with pHPT require surgery due to risk for osteoporosis, renal stones, and possibly silent complications of renal impairment, cardiovascular disease, and common psychiatric disability. Genetic studies have advanced, but the cause of the disease remains unclear for most patients. Localization methods for parathyroid tumors have improved and increased the interest for less invasive operative methods with shorter hospital stays and reduced costs for the patient. It is important to delineate when this really will imply progress and to use the new diagnostic methods in discussions of appropriate treatment strategies. It has also become evident that older pHPT patients especially could benefit from medical treatment of bone mineral deficit, and they may also need vitamin D or vitamin D analogues to prevent progress of the disease.
SUMMARY: pHPT is a common disorder among postmenopausal women, in whom most commonly applied surgical treatment has proven markedly efficient. There is now increased interest to better understand possible causes of the disease and schedule the most efficient surgical and medical treatment and discuss possible prophylaxis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14685084     DOI: 10.1097/00001622-200401000-00002

Source DB:  PubMed          Journal:  Curr Opin Oncol        ISSN: 1040-8746            Impact factor:   3.645


  4 in total

Review 1.  Molecular genetics of parathyroid disease.

Authors:  Gunnar Westin; Peyman Björklund; Göran Akerström
Journal:  World J Surg       Date:  2009-11       Impact factor: 3.352

2.  Cancer of ectopic parathyroid gland presentation of the disease with a case report.

Authors:  Jovan P Pesovic; Bojan Z Milosevic; Dragan S Canovic; Aleksandar M Cvetkovic; Milos Z Milosavljevic; Jasna D Jevdjic; Mladen D Pavlovic; Marko D Petrovic
Journal:  Int J Clin Exp Med       Date:  2013-03-21

3.  An LRP5 receptor with internal deletion in hyperparathyroid tumors with implications for deregulated WNT/beta-catenin signaling.

Authors:  Peyman Björklund; Göran Akerström; Gunnar Westin
Journal:  PLoS Med       Date:  2007-11-27       Impact factor: 11.069

4.  Stabilizing mutation of CTNNB1/beta-catenin and protein accumulation analyzed in a large series of parathyroid tumors of Swedish patients.

Authors:  Peyman Björklund; Daniel Lindberg; Göran Akerström; Gunnar Westin
Journal:  Mol Cancer       Date:  2008-06-09       Impact factor: 27.401

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.